Company Profile
Updated: 09-SEP-09GDC Inc.
Exporter
PO Box 98, Goshen, IN 46527, United States
(574)533-3128, (574)534-1777 fax,
Primary SIC: Plastics Foam Products, Primary NAICS: Urethane and Other Foam Product (except Polystyrene) Manufacturing
Description: Manufacturing: Manufactures plastic foam products; manufactures adhesives and sealants; manufactures medical and laboratory rubber sundries and related products; manufactures industrial organic chemicals; manufactures synthetic rubber
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Curis to Present at Lazard Capital Markets Annual Healthcare Conference.(Conference news)
Health & Beauty Close-Up; 11/17/2009; 550 words; Curis, Inc., a drug development company seeking to develop...Officer, will provide an overview of the status of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor. GDC-0449 is currently being developed in Phase II...
Studies from Genentech, Inc. yield new data on medulloblastoma.(Clinical report)
Cancer Weekly; 11/17/2009; 909 words; ...after an initial response to GDC-0449, we determined the mutational...but disrupted the ability of GDC-0449 to bind SMO and suppress...same amino acid also arose in a GDC-0449-resistant mouse model...and colleagues, Genentech, Inc (see also Medulloblastoma...
Curis to Present at Lazard Capital Markets 6th Annual Healthcare Conference.(Conference news)
Business Wire; 11/11/2009; 694 words; CAMBRIDGE, Mass. -- Curis, Inc. (NASDAQ: CRIS), a drug development...provide an overview of the status of GDC-0449, an orally-administered small...at www.curis.com. About Curis, Inc. Curis is a drug development company...
Curis to Present at the Oppenheimer 20th Annual Healthcare Conference.(Conference news)
Cancer Weekly; 11/10/2009; 958 words; Curis, Inc. (NASDAQ: CRIS), a...City (see also Curis, Inc.). Dan Passeri, Curis...overview of the status of GDC-0449, an orally-administered...Hedgehog Pathway Inhibitor. GDC-0449 is currently being...curis.com. About Curis, Inc. Curis is a drug development...
Curis Reports Third Quarter 2009 Financial Results.(Financial report)
Cancer Weekly; 11/10/2009; 2004 words; Curis, Inc. (NASDAQ:CRIS), a drug development...September 30, 2009 (see also Curis, Inc.). "The third quarter of 2009...encouraging Phase I clinical data on GDC-0449, a Hedgehog pathway inhibitor...quarter of 2009. -- Publication of GDC-0449 Ph
Recent News Articles
- Court Cases.(on the record)(Emigrant Mortgage Company Inc. filed a case against Cohen and Wolf P.C.)(ConnectiCare Inc. filed a case against GDC Financial Group Inc.)(Richard Kozek filed a case against General Electric Co.)
Fairfield County Business Journal - April 17, 2006 - GDC's new DSLware products deliver next gen DSL Technology that supports wired and wireless access for Internet based services including video and VoIP.(digital subscriber line, voice over internet protocol, General DataComm Industries Inc.)(DSLware ADSL2/2+)
EDP Weekly's IT Monitor - January 24, 2005 - GDC's new DSLware products deliver next gen DSL technology.(General DataComm Industries Inc., Digital Subscriber Line)
Software Industry Report - January 24, 2005 - Dynavar Networking, Inc. Signs Partner Agreement to Promote and Sell GDC's Full Line of Network Access Solutions.
Business Wire - April 27, 2004
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
%20manufacturing%20%20&custom5=%20in%20&position=1)